Advertisement

In vitro-Verfahren zur Bestimmung der Prognose und individuellen Therapie von Patienten mit nichtkleinzelligen Bronchialkarzinomen

Zusammenfassung

Eine eindeutige histologische Klassifizierung der Bronchialkarzinome bereitet immer wieder Schwierigkeiten. Vor allem nichtkleinzellige Bronchialkarzinome stellen eine Mischgruppe von Tumoren dar, welche eine Überlappung der histologischen Typen zeigen, aber auch fließende Übergänge in ihren biologischen Merkmalen und in ihrem klinischen Verlauf aufweisen. Eine Voraussage der Progression dieser Tumoren und der Überlebenszeit der Patienten ist daher mit Unsicherheiten belastet. Das Ziel einer mit der Klinik für Thoraxerkrankungen in Heidelberg-Rohrbach durchgeführten Studie war es daher, neben den bisher bekannten prognostischen Faktoren nach weiteren zellulären prognostischen Indikatoren bei diesen Tumoren zu suchen (Volm et al. 1985b, 1988c, d, g).

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Abel U, Berger S, Wiebelt H (1984) Critlevel. An exploratory procedure for the evaluation of quantitative prognostic factors. Methods Inf Med 23:154–156PubMedGoogle Scholar
  2. Biedler JL, Chang T, Meyers MB, Peterson RHF, Sprengler BA (1983) Drug resistance in Chinese hamster lung and mouse tumor cells. Cancer Treat Rep 67:859–867PubMedGoogle Scholar
  3. Emdin SO, Stenling R, Roos G (1987) Prognostic value of DNA content in colorectal carcinoma. A flow cytometric study with some methodologic aspects. Cancer 60:1282–1287PubMedCrossRefGoogle Scholar
  4. Group of Sensitivity Testing of Tumors (KSST) (1981) In vitro shortterm test to determine the resistance of human tumors to Chemotherapy. Cancer 48:2127–2135CrossRefGoogle Scholar
  5. Haag D (1980) Flow microfluorometric deoxyribonucleic acid (DNA) analysis supplementing routine histopathologic diagnosis of biopsy specimens. Lab Invest 42:85–90PubMedGoogle Scholar
  6. Hedley DW, Friedlander ML, Taylor IW, Rugg CA, Musgrowe EA (1983) Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry. J Histochem Cytochem 31:1333–1335PubMedCrossRefGoogle Scholar
  7. Hedley DW, Friedlander ML, Taylor IW (1985) Application of DNA flow cytometry to paraffinembedded archival material for the study of aneuploidy and its clinical significance. Cytometry 6:327–333PubMedCrossRefGoogle Scholar
  8. Kallioniemi OP, Blanco G, Alavaikko et al. (1988) Improving the prognostic value of DNA flow cytometry in breast cancer by combining DNA index and S-phase fraction. Cancer 62:2183–2190PubMedCrossRefGoogle Scholar
  9. Klemi PJ, Joensun H, Kilholma P, Mäenpää J (1988) Clinical significance of abnormal nuclear DNA content in serous ovarian tumors. Cancer 62:2005–2010PubMedCrossRefGoogle Scholar
  10. Mattern J, Bäk M, Volm M (1987) Occurence of a multidrug-resistant phenotype in human lung xenografts. Br J Cancer 56:407–411PubMedCrossRefGoogle Scholar
  11. Mattern J, Bäk M, Hoever KH, Volm M (1988) Development of drug resistance in a human epidermoid lung carcinoma xenograft line. Br J Cancer 38:30–33CrossRefGoogle Scholar
  12. Riordan JR, Ling V (1985) Genetic and biochemical characterization of multidrug resistance. Pharmacol Ther 28:51–75PubMedCrossRefGoogle Scholar
  13. Stephenson RA, James BC, Gay H, Fair WR, Whitmore WF, Melamed MR (1987) Flow cytometry of prostate cancer. Relationship of DNA content to survival. Cancer Res 47:2504–2509PubMedGoogle Scholar
  14. Volm M (1983) Short-term incubation test. In: Grundmann E (Ed) Cancer Campaign, vol 7. Fischer, Stuttgart, pp 71–81Google Scholar
  15. Volm M, Wayss K, Kaufmann M, Mattern J (1979) Pretherapeutic detection of tumour resistance and the results of tumor chemotherapy. Eur J Cancer 15:983–993PubMedGoogle Scholar
  16. Volm M, Mattern J, Sonka J, Vogt-Schaden M, Wayss K (1985a) DNA distribution in non-small cell lung carcinomas and its relationship to clinical behavior. Cytometry 6:345–356CrossRefGoogle Scholar
  17. Volm M, Drings P, Mattern J, Sonka J, Vogt-Moykopf I, Wayss K (1985b) Prognostic significance of DNA pattern and resistance-predictive tests in non-small cell lung carcinoma. Cancer 56:1396–1403PubMedCrossRefGoogle Scholar
  18. Volm M, Bäk M, Mattern J (1988a) Intrinsic drug resistance in a human lung carcinoma xenograft is associated with overexpression of multidrugresistance DNA-sequences and of plasma membrane glycoproteins. Arzneimittelforsch 38:1189–1193PubMedGoogle Scholar
  19. Volm M, Bäk M, Efferth Th, Mattern J (1988b) Induced multidrugresistance in murine sarcoma 180 cells grown in vitro and in vivo and associated changes in expression of multidrugresistance DNA-sequences and membrane glycoproteins. Anticancer Res 8:1169–1178PubMedGoogle Scholar
  20. Volm M, Mattern J, Müller T, Drings P (1988c) Flow cytometry of epidermoid lung carcinomas: Relationship of ploidy and cell cycle phases to survival. A five-year follow up study. Anticancer Res 8:105–112PubMedGoogle Scholar
  21. Volm M, Mattern J, Müller T, Vogt-Moykopf I (1988d) Flow cytometry in human adenocarcinoma of the lung: Prognostic significance for survival. Tum Diagn Ther 9:177–181Google Scholar
  22. Volm M, Bäk M, Efferth TH, Lathan B, Mattern J (1988e) Immunocytochemical detection of a resistance associated glycoprotein in tissue culture cells, ascites tumors and human tumor xenografts by Mab 265/F4. Anticancer Res 8:531–536PubMedGoogle Scholar
  23. Volm M, Bäk M, Hahn EW, Mattern J, Weber E (1988f) DNA and S-phase distribution and incidence of metastasis in human primary lung carcinoma. Cytometry 9:183–188PubMedCrossRefGoogle Scholar
  24. Volm M, Hahn EW, Mattern J, Müller T, Vogt-Moykopf I, Weber E (1988g) Five-year followup study of independent clinical and flow cytometric prognostic factors for the survival of patients with non-small cell lung carcinoma. Cancer Res 48:2923–2928PubMedGoogle Scholar
  25. Yonemura Y, Sugiyama K, Fujimura T et al. (1988) Correlation of DNA ploidy and proliferative activity in human gastric cancer. Cancer 62:1497–1502PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag, Berlin Heidelberg 1991

Authors and Affiliations

  • M. Volm

There are no affiliations available

Personalised recommendations